All HIV articles – Page 6
-
NewsProtein may pave way to eliminating HIV latency
Researchers have identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor that shuts down viral protein production and helps virus-infected cells to escape from anti-HIV therapy and immune responses.
-
NewsHIV targeted with novel dual gene-editing approach
Gene-editing therapy aimed at two targets – HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells – can effectively eliminate HIV infection, new research shows.
-
NewsResearchers ID plant-based compound that inhibits reactivation of the HIV viral reservoir
Researchers have zeroed in on a promising compound that targets HIV reservoirs that persist in people living with HIV despite the presence of anti-HIV therapy.
-
NewsStudy outlines world’s third successful cure of HIV infection after stem cell transplantation
The ‘Düsseldorf patient’, a 53-year-old man, is now the third person in the world to be completely cured of HIV with a stem cell transplant.
-
NewsClinicians ID severe form of mpox with high mortality in people with advanced HIV
An international collaboration of clinicians has identified a severe, necrotising form of mpox with a high mortality in immunosuppressed people living with HIV.
-
NewsHIV vaccine candidate aims to block virus before it takes root
The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.
-
NewsScientists find two separate reservoirs of latent HIV in patients
Scientists have shown that, addition to HIV’s ability to lay dormant in the blood/lymphoid system, the virus may also lay dormant in the central nervous system, delineating another challenge in creating a cure.
-
NewsCannabis shows potential as weapon in the fight against COVID-19
Cannabis could become an important weapon in the battle against Covid-19, with a new review suggesting both cannabinoids and terpenes show great promise in lab research, due to their antiviral qualities.
-
NewsHIV infection leaves memory that persists in cells even when virus is gone
A new study explains why people living with HIV may suffer from chronic inflammation, which can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction and how suppression or even eradication of HIV in the body may not resolve it. ...
-
NewsMethod for singling out HIV virus’s most dangerous parts could lead to new drugs
A new technique could make it possible to identify the most dangerous parts of the HIV virus, so they can be singled out for attack.
